Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kensei Yamaguchi
Large‐Scale, Prospective Observational Study of Regorafenib in Japanese Patients With Metastatic Colorectal Cancer in a Real‐World Clinical Setting
Oncologist
Cancer Research
Medicine
Oncology
Favorable Long-Term Outcomes of One-Year Adjuvant S-1 Monotherapy for Pathological Stage II or III Gastric Cancer Treated at a High-Volume Center
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Clinical Significance of Intratumoral HER2 Heterogeneity on Trastuzumab Efficacy Using Endoscopic Biopsy Specimens in Patients With Advanced HER2 Positive Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
A Phase I Study of Intravenous Aflibercept With FOLFIRI in Japanese Patients With Previously Treated Metastatic Colorectal Cancer
Investigational New Drugs
Oncology
Pharmacology
Third- Or Later-Line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice
Clinical Colorectal Cancer
Oncology
Gastroenterology
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of Two Randomized Clinical Trials
Clinical Colorectal Cancer
Oncology
Gastroenterology
Early Change in Circulating Tumor DNA as a Potential Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer
Scientific Reports
Multidisciplinary
A Phase II Study of NK012, a Polymeric Micelle Formulation of SN-38, in Unresectable, Metastatic or Recurrent Colorectal Cancer Patients
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
P1-060a Phase II Study of Nab-PTX in Combination With RAM in Patients With Pre-Treated AGC: Results of Final Analysis
Annals of Oncology
Medicine
Oncology
Hematology
Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
1
2
›
